CHE Fundamental Analysis - CHEMED CORP

Fundamental Rating

We assign a fundamental rating of 7 out of 10 to CHE. CHE was compared to 101 industry peers in the Health Care Providers & Services industry. CHE gets an excellent profitability rating and is at the same time showing great financial health properties. CHE has a valuation in line with the averages, but on the other hand it scores bad on growth.

Quickly go to:

1. Profitability

1.1 Basic Checks

In the past year CHE was profitable.

In the past year CHE had a positive cash flow from operations.

In the past 5 years CHE has always been profitable.

In the past 5 years CHE always reported a positive cash flow from operatings.

1.2 Ratios

Looking at the Return On Assets, with a value of 16.90%, CHE belongs to the top of the industry, outperforming 100.00% of the companies in the same industry.

CHE has a better Return On Equity (24.23%) than 92.08% of its industry peers.

The Return On Invested Capital of CHE (20.52%) is better than 95.05% of its industry peers.

Measured over the past 3 years, the Average Return On Invested Capital for CHE is significantly above the industry average of 9.19%.

		Industry Rank	Sector Rank
ROA	16.9%
ROE	24.23%
ROIC	20.52%

ROA(3y)17.25%

ROA(5y)18.8%

ROE(3y)27.61%

ROE(5y)32.28%

ROIC(3y)21.96%

ROIC(5y)22.92%

1.3 Margins

CHE has a better Profit Margin (11.56%) than 97.03% of its industry peers.

CHE's Profit Margin has improved in the last couple of years.

With an excellent Operating Margin value of 15.49%, CHE belongs to the best of the industry, outperforming 91.09% of the companies in the same industry.

In the last couple of years the Operating Margin of CHE has grown nicely.

With a decent Gross Margin value of 33.65%, CHE is doing good in the industry, outperforming 65.35% of the companies in the same industry.

CHE's Gross Margin has improved in the last couple of years.

		Industry Rank	Sector Rank
OM	15.49%
PM (TTM)	11.56%
GM	33.65%

OM growth 3Y-0.29%

OM growth 5Y3.39%

PM growth 3Y-0.36%

PM growth 5Y1.83%

GM growth 3Y-0.79%

GM growth 5Y1.99%

More info and screens

ROA

ROE

ROIC

Operating and Profit Margin

Show most profitable peers

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is well above the Cost of Capital (WACC), so CHE is creating value.

The number of shares outstanding for CHE has been reduced compared to 1 year ago.

Compared to 5 years ago, CHE has less shares outstanding

There is no outstanding debt for CHE. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.

2.2 Solvency

An Altman-Z score of 12.37 indicates that CHE is not in any danger for bankruptcy at the moment.

The Altman-Z score of CHE (12.37) is better than 94.06% of its industry peers.

CHE has a debt to FCF ratio of 0.00. This is a very positive value and a sign of high solvency as it would only need 0.00 years to pay back of all of its debts.

CHE has a better Debt to FCF ratio (0.00) than 94.06% of its industry peers.

A Debt/Equity ratio of 0.00 indicates that CHE is not too dependend on debt financing.

CHE's Debt to Equity ratio of 0.00 is amongst the best of the industry. CHE outperforms 88.12% of its industry peers.

		Industry Rank	Sector Rank
Debt/Equity	0
Debt/FCF	0
Altman-Z	12.37

ROIC/WACC2.36

WACC8.7%

2.3 Liquidity

CHE has a Current Ratio of 1.86. This is a normal value and indicates that CHE is financially healthy and should not expect problems in meeting its short term obligations.

CHE has a Current ratio of 1.86. This is in the better half of the industry: CHE outperforms 68.32% of its industry peers.

A Quick Ratio of 1.83 indicates that CHE should not have too much problems paying its short term obligations.

The Quick ratio of CHE (1.83) is better than 69.31% of its industry peers.

		Industry Rank	Sector Rank
Current Ratio	1.86
Quick Ratio	1.83

More info and screens

WACC

Debt/Equity

How to determine the health of a company

Altman-Z score

Show peers with great health

3. Growth

3.1 Past

CHE shows a slight negative growth in Earnings Per Share. In the last year, the EPS has decreased by -0.97%.

CHE shows quite a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 10.64% yearly.

The Revenue has been growing slightly by 7.55% in the past year.

The Revenue has been growing slightly by 4.63% on average over the past years.

EPS 1Y (TTM)-0.97%

EPS 3Y6.14%

EPS 5Y10.64%

EPS Q2Q%-21.94%

Revenue 1Y (TTM)7.55%

Revenue growth 3Y4.36%

Revenue growth 5Y4.63%

Sales Q2Q%3.85%

3.2 Future

The Earnings Per Share is expected to grow by 5.61% on average over the next years.

Based on estimates for the next years, CHE will show a small growth in Revenue. The Revenue will grow by 5.12% on average per year.

EPS Next Y-3.48%

EPS Next 2Y4.82%

EPS Next 3Y5.61%

EPS Next 5YN/A

Revenue Next Year5.02%

Revenue Next 2Y5.86%

Revenue Next 3Y5.12%

Revenue Next 5YN/A

3.3 Evolution

The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.

The Revenue growth rate is stable: in the next years the growth will be about the same than in the last years.

More info and screens

Find the best growth stocks

Show best growing peers

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 20.49, CHE is valued on the expensive side.

Based on the Price/Earnings ratio, CHE is valued a bit cheaper than 69.31% of the companies in the same industry.

CHE is valuated rather cheaply when we compare the Price/Earnings ratio to 27.41, which is the current average of the S&P500 Index.

The Price/Forward Earnings ratio is 18.02, which indicates a rather expensive current valuation of CHE.

CHE's Price/Forward Earnings ratio is a bit cheaper when compared to the industry. CHE is cheaper than 65.35% of the companies in the same industry.

CHE's Price/Forward Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 22.88.

		Industry Rank	Sector Rank
PE	20.49
Fwd PE	18.02

4.2 Price Multiples

CHE's Enterprise Value to EBITDA ratio is in line with the industry average.

Compared to the rest of the industry, the Price/Free Cash Flow ratio of CHE indicates a somewhat cheap valuation: CHE is cheaper than 69.31% of the companies listed in the same industry.

		Industry Rank	Sector Rank
P/FCF	17.98
EV/EBITDA	14.16

4.3 Compensation for Growth

CHE has an outstanding profitability rating, which may justify a higher PE ratio.

PEG (NY)N/A

PEG (5Y)1.93

EPS Next 2Y4.82%

EPS Next 3Y5.61%

More info and screens

Show best valued peers

5. Dividend

5.1 Amount

CHE has a yearly dividend return of 0.52%, which is pretty low.

CHE's Dividend Yield is rather good when compared to the industry average which is at 2.43. CHE pays more dividend than 80.20% of the companies in the same industry.

With a Dividend Yield of 0.52, CHE pays less dividend than the S&P500 average, which is at 2.38.

		Industry Rank	Sector Rank
Dividend Yield	0.52%

5.2 History

The dividend of CHE is nicely growing with an annual growth rate of 8.02%!

CHE has been paying a dividend for at least 10 years, so it has a reliable track record.

CHE has not decreased their dividend for at least 10 years, which is a reliable track record.

Dividend Growth(5Y)8.02%

Div Incr Years16

Div Non Decr Years21

5.3 Sustainability

10.17% of the earnings are spent on dividend by CHE. This is a low number and sustainable payout ratio.

CHE's earnings are growing slower than its dividend. This means the dividend growth is not sustainable.

DP10.17%

EPS Next 2Y4.82%

EPS Next 3Y5.61%

More info and screens

Find the best dividend stocks

Show peers with best dividend

CHEMED CORP

NYSE:CHE (9/18/2025, 8:04:00 PM)

After market: 458.25 0 (0%)

458.25

+0.89 (+0.19%)

Chartmill FA Rating

GICS SectorHealth Care

GICS IndustryGroupHealth Care Equipment & Services

GICS IndustryHealth Care Providers & Services

Earnings (Last)07-29 2025-07-29/amc

Earnings (Next)10-27 2025-10-27/amc

Inst Owners96.53%

Inst Owner Change-1.96%

Ins Owners1.59%

Ins Owner Change-4.51%

Market Cap6.68B

Analysts82.5

Price Target590.07 (28.77%)

Short Float %2.87%

Short Ratio2.32

Dividend

		Industry Rank	Sector Rank
Dividend Yield	0.52%

Yearly Dividend1.83

Dividend Growth(5Y)8.02%

DP10.17%

Div Incr Years16

Div Non Decr Years21

Ex-Date08-11 2025-08-11 (0.6)

Surprises & Revisions

EPS beat(2)1

Avg EPS beat(2)-7.3%

Min EPS beat(2)-15.11%

Max EPS beat(2)0.5%

EPS beat(4)1

Avg EPS beat(4)-4.49%

Min EPS beat(4)-15.11%

Max EPS beat(4)0.5%

EPS beat(8)3

Avg EPS beat(8)-1.89%

EPS beat(12)5

Avg EPS beat(12)-1.91%

EPS beat(16)9

Avg EPS beat(16)-0.16%

Revenue beat(2)0

Avg Revenue beat(2)-1.36%

Min Revenue beat(2)-2.53%

Max Revenue beat(2)-0.19%

Revenue beat(4)0

Avg Revenue beat(4)-1.27%

Min Revenue beat(4)-2.53%

Max Revenue beat(4)-0.19%

Revenue beat(8)1

Avg Revenue beat(8)-1.12%

Revenue beat(12)2

Avg Revenue beat(12)-1.04%

Revenue beat(16)3

Avg Revenue beat(16)-1.15%

PT rev (1m)1.98%

PT rev (3m)-14.59%

EPS NQ rev (1m)0.47%

EPS NQ rev (3m)-13.29%

EPS NY rev (1m)-5.22%

EPS NY rev (3m)-12.53%

Revenue NQ rev (1m)0.14%

Revenue NQ rev (3m)-4.88%

Revenue NY rev (1m)-0.23%

Revenue NY rev (3m)-3.3%

Valuation

		Industry Rank	Sector Rank
PE	20.49
Fwd PE	18.02
P/S	2.66
P/FCF	17.98
P/OCF	15.64
P/B	5.57
P/tB	15.03
EV/EBITDA	14.16

EPS(TTM)22.37

EY4.88%

EPS(NY)25.43

Fwd EY5.55%

FCF(TTM)25.49

FCFY5.56%

OCF(TTM)29.29

OCFY6.39%

SpS172.4

BVpS82.26

TBVpS30.48

PEG (NY)N/A

PEG (5Y)1.93

Profitability

		Industry Rank	Sector Rank
ROA	16.9%
ROE	24.23%
ROCE	26.76%
ROIC	20.52%
ROICexc	24.78%
ROICexgc	66.31%
OM	15.49%
PM (TTM)	11.56%
GM	33.65%
FCFM	14.79%

ROA(3y)17.25%

ROA(5y)18.8%

ROE(3y)27.61%

ROE(5y)32.28%

ROIC(3y)21.96%

ROIC(5y)22.92%

ROICexc(3y)25.21%

ROICexc(5y)25.79%

ROICexgc(3y)67.33%

ROICexgc(5y)75.46%

ROCE(3y)28.73%

ROCE(5y)30.03%

ROICexcg growth 3Y-5.61%

ROICexcg growth 5Y0.34%

ROICexc growth 3Y-1.58%

ROICexc growth 5Y4.43%

OM growth 3Y-0.29%

OM growth 5Y3.39%

PM growth 3Y-0.36%

PM growth 5Y1.83%

GM growth 3Y-0.79%

GM growth 5Y1.99%

F-Score7

Asset Turnover1.46

Health

		Industry Rank	Sector Rank
Debt/Equity	0
Debt/FCF	0
Debt/EBITDA	0
Cap/Depr	86.82%
Cap/Sales	2.21%
Interest Coverage	250
Cash Conversion	94.24%
Profit Quality	127.91%
Current Ratio	1.86
Quick Ratio	1.83
Altman-Z	12.37

F-Score7

WACC8.7%

ROIC/WACC2.36

Cap/Depr(3y)89.59%

Cap/Depr(5y)94.39%

Cap/Sales(3y)2.41%

Cap/Sales(5y)2.56%

Profit Quality(3y)107.8%

Profit Quality(5y)110.23%

High Growth Momentum

Growth

EPS 1Y (TTM)-0.97%

EPS 3Y6.14%

EPS 5Y10.64%

EPS Q2Q%-21.94%

EPS Next Y-3.48%

EPS Next 2Y4.82%

EPS Next 3Y5.61%

EPS Next 5YN/A

Revenue 1Y (TTM)7.55%

Revenue growth 3Y4.36%

Revenue growth 5Y4.63%

Sales Q2Q%3.85%

Revenue Next Year5.02%

Revenue Next 2Y5.86%

Revenue Next 3Y5.12%

Revenue Next 5YN/A

EBIT growth 1Y-1.51%

EBIT growth 3Y4.05%

EBIT growth 5Y8.18%

EBIT Next Year15.45%

EBIT Next 3Y10.26%

EBIT Next 5YN/A

FCF growth 1Y32.69%

FCF growth 3Y13.77%

FCF growth 5Y8.19%

OCF growth 1Y23.7%

OCF growth 3Y10.6%

OCF growth 5Y6.75%

CHEMED CORP (CHE) Stock Fundamental Analysis

1. Profitability

1.1 Basic Checks

1.2 Ratios

1.3 Margins

More info and screens

2. Health

2.1 Basic Checks

2.2 Solvency

2.3 Liquidity

More info and screens

3. Growth

3.1 Past

3.2 Future

3.3 Evolution

More info and screens

4. Valuation

4.1 Price/Earnings Ratio

4.2 Price Multiples

4.3 Compensation for Growth

More info and screens

5. Dividend

5.1 Amount

5.2 History

5.3 Sustainability

More info and screens